Psychiatric Journals
Psychiatry
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Psychiatry
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Psychiatry
        Anxiety
        Child/Adolescent Psych
        Eating Disorders
        Economics of Medicine
        Geriatric Psych
        Mood Disorders
        Neuro/Psych Pharmacol
        Neuropsych Sciences
        Other Psychiatry
        Pain Management
        Personality Disorders
        Popular Press
        Psychotherapy/analysis
        Schizophrenia/Psychosis
        Substance Abuse
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
post partum depression  post partum depression
ssri  ssri
pervasive developmental  pervasive developmental
adhd  adhd
alzheimer's  alzheimer's
nervosa  nervosa
ptsd  ptsd
bipolar  bipolar
personality  personality
methamphetamine  methamphetamine
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
Use of antipsychotics in neuropsychiatric symptoms of dementia
Kalapatapu RK et al. - Antipsychotic medications have a modest effect on the neuropsychiatric symptoms of dementia, but product labels warn of the excess risk of death and morbidity associated with their use in older patients. As such, these agents should not be the first choice for the treatment of behavioral and psychotic symptoms of dementia. Nevertheless, a trial of these agents may be indicated in instances in which the severity of symptoms is extreme, or symptoms do not respond to nonpharmacologic methods or other medications...There is no evidence to suggest differences in effectiveness between atypical and conventional antipsychotics; therefore, the choice of an antipsychotic for neuropsychiatric symptoms often relies on side effect profile and individual patient circumstances. Extrapyramidal symptoms and QTc prolongation are concerns with conventional antipsychotic agents. The incidence of cerebrovascular events with either atypical or conventional antipsychotics appears increased compared with placebo. A discussion of the risk-benefit ratio of antipsychotics with the patient's family and/or caregivers should precede the decision to use these agents. [more...]
Sponsor

Read a Different Specialty

Psychiatric News
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Psychiatric News Profession Index

Psychiatric News
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.